You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Estrogen receptor agonist

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer Trial (Giredestrant, Fulvestrant, Abemaciclib)

Not yet recruiting
  • Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
  • (no location specified)
Sep 26, 2023

Breast Cancer Trial in Worldwide (GDC-9545, Palbociclib, LHRH Agonist)

Active, not recruiting
  • Breast Cancer
  • Aurora, Colorado
  • +23 more
Jan 30, 2023

Oral Thrombopoietin Receptor Agonist in Pediatric Chronic ITP

Not yet recruiting
  • Thrombopoietin Receptor Agonist
    • (no location specified)
    May 4, 2023

    Breast Cancer Trial in Worldwide (GDC-0810, LHRH Agonist, Palbociclib)

    Terminated
    Has Results
    • Breast Cancer
    • San Diego, California
    • +13 more
    May 25, 2021

    Incidence of Retained Gastric Food on Endoscopy

    Not yet recruiting
    • Gastric Content Aspiration
    • Esophagogastroduodenoscopy
    • (no location specified)
    May 16, 2023

    Estrogen Receptor (ER) PET/CT Imaging in Breast Cancer

    Recruiting
    • Breast Cancer
    • +2 more
      • Wuhan, Hubei, China
        TongjiHospital
      Sep 12, 2022

      Glaucoma, Suspect, Aberration, Corneal Wavefront Trial in Banha (Low dosage selective alpha-2 receptor agonists topical eyedrop,

      Recruiting
      • Glaucoma, Suspect
      • Aberration, Corneal Wavefront
      • Low dosage selective alpha-2 receptor agonists topical eyedrop
      • High dosage selective alpha-2 receptor agonists topical eyedrop
      • Banhā, QA, Egypt
        Ahmed Abdelshafy
      Jan 2, 2023

      Low Grade Serous Ovarian Carcinoma, Adult Type Granulosa Cell Tumor Trial in Gent, Leuven, Liège (Abemaciclib, Letrozole)

      Not yet recruiting
      • Low Grade Serous Ovarian Carcinoma
      • Adult Type Granulosa Cell Tumor
      • Gent, Oost-Vlaanderen, Belgium
      • +2 more
      May 12, 2023

      Pulmonary Arterial Hypertension Trial in Tempe (Prostacyclin Receptor Agonist)

      Recruiting
      • Pulmonary Arterial Hypertension
      • Prostacyclin Receptor Agonist
      • Tempe, Arizona
        Celerion
      Aug 16, 2022

      Breast Cancer Stage IV Trial in Irvine (Gallium-68)

      Recruiting
      • Breast Cancer Stage IV
      • Irvine, California
        Hoag Memorial Hospital Presbyterian
      May 26, 2023

      Breast Cancer, Brain Metastases Trial in New York (Brain Imaging with 18F-FES)

      Not yet recruiting
      • Breast Cancer
      • Brain Metastases
      • Brain Imaging with 18F-FES
      • New York, New York
        New York-Presbyterian/Weill Cornell Medical Center
      Oct 2, 2023

      Caveolin 1 Deficiency in Response to Glucagon-like Peptide 1

      Not yet recruiting
      • Overweight and Obesity
      • 24-hour ambulatory blood pressure
      • Liberal salt diet
      • (no location specified)
      Oct 4, 2023

      Toremifene, Tamoxifen, and Aromatase Inhibitor Plus Ovarian

      Not yet recruiting
      • Hormone-receptor-positive Breast Cancer
      • +3 more
      • Aromatase inhibitor
      • +3 more
      • Guangzhou, Guangdong, China
        Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
      Apr 5, 2023

      Breast Cancer Trial in Sarasota, Nashville (AC699)

      Recruiting
      • Breast Cancer
      • Sarasota, Florida
      • +1 more
      Jan 3, 2023

      Hormone Receptor Positive HER-2 Negative Breast Cancer Trial in Shanghai (Docetaxel, Carboplatin, Epirubicin)

      Recruiting
      • Hormone Receptor Positive HER-2 Negative Breast Cancer
      • Shanghai, Shanghai, China
        Breast cancer institute of Fudan University Cancer Hospital
      Jun 12, 2023

      Breast Cancer Trial in Orange City (ARV-471 (PF-07850327), Palbociclib, Letrozole)

      Recruiting
      • Breast Cancer
      • ARV-471 (PF-07850327)
      • +2 more
      • Orange City, Florida
        Mid Florida Hematology and Oncology Center
      Jun 8, 2023

      Stroke, Stroke, Acute, Stroke, Ischemic Trial in Linyi, Hong Kong (Semaglutide)

      Recruiting
      • Stroke
      • +3 more
      • Linyi, Shangdong, China
      • +1 more
      Jun 24, 2023

      Estrogen Receptor Positive Breast Cancer Trial in Edmonton (Estradiol)

      Active, not recruiting
      • Estrogen Receptor Positive Breast Cancer
      • Edmonton, Alberta, Canada
        Cross Cancer Institute
      Feb 1, 2023

      Breast Cancer Trial in Beijing, Zhengzhou, Changsha (EG017)

      Not yet recruiting
      • Breast Cancer
      • Beijing, Benjing, China
      • +2 more
      Dec 30, 2022

      Breast Tumors Trial in Chuo Ku, Koto-Ku (H3B-6545, Antihistamine)

      Active, not recruiting
      • Breast Neoplasms
      • Chuo Ku, Japan
      • +1 more
      Dec 19, 2022

      Estrogen Receptor Positive Breast Cancer, Breast Cancer Trial in Houston (ESTRING, Replens)

      Recruiting
      • Estrogen Receptor Positive Breast Cancer
      • Breast Cancer
      • Houston, Texas
        Houston Methodist Cancer Center
      Nov 18, 2022

      Locally Advanced or Metastatic Breast Cancer Trial in Worldwide (Phesgo, Giredestrant, Docetaxel)

      Recruiting
      • Locally Advanced or Metastatic Breast Cancer
      • Los Angeles, California
      • +21 more
      Jul 25, 2022

      Glucagon-like Peptide-1 Receptor Agonists According to Type 2

      Recruiting
      • Diabetes Mellitus, Type 2
      • GLP-1 receptor agonist
      • Bari, Italy
        Azienda Ospedaliero-Universitaria Policlinico Bari
      Nov 4, 2023

      Neuroendocrine Tumors, Progesterone Receptor Positive Tumor, Estrogen Receptor Positive Tumor Trial in São Paulo (Tamoxifen)

      Active, not recruiting
      • Neuroendocrine Tumors
      • +2 more
      • Tampa, Florida
      • +1 more
      Jan 13, 2023

      Metastatic Breast Cancer Trial (Elacestrant)

      Not yet recruiting
      • Metastatic Breast Cancer
      • (no location specified)
      Oct 24, 2022